| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |